Viewing nowFlorine 250 mg (Ciprofloxacin Hydrochloride Hydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

MFDS item code 201800924 · Approved 2018.02.26
Treatment of genitourinary, respiratory and otorhinolaryngologic, and other infections (skin, abdominal, eye, etc.)
This medication is used to treat infections caused by various bacteria. It is particularly effective against several harmful bacteria including Escherichia coli, Shigella, and Salmonella. It is suitable for the treatment of respiratory infections excluding acute bronchitis and community-acquired pneumonia, and it is also used for infections of the ear, nose, and throat. Furthermore, it helps with bacterial prostatitis, acute urinary tract infections, gonococcal cervicitis and urethritis, gastrointestinal infections, and infections of bile ducts. It is used to treat bacterial infections in various sites including skin and soft tissue infections, bone and joint infections, gynecological infections, and peritonitis; however, its use prior to surgery is restricted. As a fluoroquinolone, there is a possibility of serious adverse reactions in some cases, hence it is used only when there are no alternative treatments for certain infections. This medication is useful for effectively treating various bacterial infections.
○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance may be calculated using the following formula. Men: {weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose may be increased to 750 mg per dose even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.
This medication may cause serious adverse effects such as tendinitis or tendon rupture, peripheral neuropathy, and central nervous system problems, so caution is advised. In particular, patients with severe myasthenia gravis may experience worsening symptoms with this medication and should not use it. If serious adverse effects occur, discontinue the medication immediately and consult a doctor. This medication should be used restrictively for certain infections and is safe only when there are no alternative treatments available. Elderly patients, those with reduced kidney function, and patients with a history of seizures should use this medication cautiously as they are at higher risk of side effects. It is safe to avoid this medication if pregnant or breastfeeding, as well as in growing children under 18 years of age and patients with epilepsy. This medication can interact with other drugs, so it is essential to inform your doctor or pharmacist if you are taking other medications. If symptoms such as muscle pain, tendon pain, visual disturbances, mental changes, or severe diarrhea occur during treatment, consult medical personnel immediately. Photosensitivity reactions may occur, so avoid strong sunlight or UV exposure, and discontinue the medication if symptoms arise. Patients with diabetes who require blood sugar control should closely monitor blood sugar fluctuations, and seek immediate treatment if hypoglycemic symptoms appear. This medication requires caution during driving or operating machinery, and symptoms may worsen if taken with alcohol. In cases of overdose, kidney function should be closely monitored, and appropriate emergency measures should be taken if necessary. This medication has not established safety in children and adolescents, so it is recommended not to use it. When storing, keep out of reach of children and avoid direct sunlight or UV exposure.
Tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin reduction, hematocrit reduction, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reactions, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremors, spasms, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, multiple neuropathy, vision disorders, color vision changes, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, appetite loss, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distention, dyspepsia, colitis accompanied by hematochezia, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, pruritus, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and spasms, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, increased serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpura, shock, hypotension, chest tightness, muscle weakness, rhabdomyolysis, cough, abnormal chest X-ray findings, eosinophilia, interstitial pneumonia, visual impairment, aortic aneurysm, aortic dissection, cardiac valve regurgitation, cardiac valve insufficiency
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. Additionally, to maintain the drug's effectiveness, it is essential to store it at room temperature between 1 degree and 30 degrees Celsius.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.